Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Altering cell membrane cholesterol affects prostate cancer survival. Lowering cholesterol inhibits the Akt pathway and induces apoptosis, while increasing it promotes tumor growth.
Area Of Science
- Biochemistry
- Cell Biology
- Oncology
Background
- Lipid rafts are membrane microdomains regulating cell signaling.
- Cholesterol content in lipid rafts influences signaling pathways.
Purpose Of The Study
- To investigate the role of lipid raft cholesterol in prostate cancer (PCa) cell survival.
- To determine if cholesterol affects the Akt/PKB pathway in PCa.
Main Methods
- Used simvastatin to inhibit cholesterol synthesis in LNCaP PCa cells.
- Manipulated cellular cholesterol levels in vitro and in vivo (SCID mice xenografts).
- Assessed Akt/PKB pathway signaling and apoptosis.
Main Results
- Simvastatin reduced raft cholesterol, inhibited Akt/PKB signaling, and induced apoptosis in PCa cells.
- Cholesterol replenishment reversed these effects and potentiated Akt activation.
- Elevated cholesterol in vivo promoted tumor growth and Akt phosphorylation while reducing apoptosis.
Conclusions
- Membrane cholesterol is crucial for Akt signaling in both normal and malignant prostate cells.
- Prostate cancer cells may rely on a cholesterol-regulated Akt pathway for survival.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
• Pneumothorax often presents...
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Primary Step: The most critical intervention for all COPD patients who smoke.
Benefits: Slows disease...